|Other Names||Non-receptor tyrosine-protein kinase TYK2, TYK2|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP3283a was selected from the region of human Phospho-TyK2-Y1054/1055. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Probably involved in intracellular signal transduction by being involved in the initiation of type I IFN signaling. Phosphorylates the interferon-alpha/beta receptor alpha chain.|
|Tissue Location||Observed in all cell lines analyzed. Expressed in a variety of lymphoid and non-lymphoid cell lines|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
TYK2 is likely involved in intracellular signal transduction via involvement in the initiation of type I IFN signaling. TYK2 Phosphorylates the interferon-alpha/beta receptor alpha chain. In animal models TYK2 is an important regulator of lymphoid tumor surveillance.
Lukashova, V., et al., J. Immunol. 171(7):3794-3800 (2003).Kiian, I., et al., Thromb. Haemost. 89(5):904-914 (2003).Ragimbeau, J., et al., EMBO J. 22(3):537-547 (2003).Trask, B., et al., Genomics 15(1):133-145 (1993).Firmbach-Kraft, I., et al., Oncogene 5(9):1329-1336 (1990).
If you have any additional inquiries please email technical services at email@example.com.